• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    New insider Mozart Aggregator Unlv Holdco L.P. claimed ownership of 14,395,879 shares and claimed ownership of 9,501,507 units of Class B Common Stock (SEC Form 3)

    2/23/26 4:30:05 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care
    Get the next $MDLN alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    Mozart Aggregator UNLV Holdco L.P.

    (Last) (First) (Middle)
    C/O BLACKSTONE INC.
    345 PARK AVENUE

    (Street)
    NEW YORK NY 10154

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    02/11/2026
    3. Issuer Name and Ticker or Trading Symbol
    Medline Inc. [ MDLN ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    Form filed by One Reporting Person
    X Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Class A Common Stock 14,394,340 I See Footnotes(1)(3)(5)(8)(9)
    Class A Common Stock 1,539 I See Footnotes(2)(4)(5)(8)(9)
    Class B Common Stock 9,501,507(6) I See Footnotes(2)(4)(5)(8)(9)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Common Units of Medline Holdings, LP (7) (7) Class A Common Stock 9,501,507 (7) I See Footnotes(2)(4)(5)(8)(9)
    1. Name and Address of Reporting Person*
    Mozart Aggregator UNLV Holdco L.P.

    (Last) (First) (Middle)
    C/O BLACKSTONE INC.
    345 PARK AVENUE

    (Street)
    NEW YORK NY 10154

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    Mozart Aggregator II UNLV Holdco L.P.

    (Last) (First) (Middle)
    C/O BLACKSTONE INC.
    345 PARK AVENUE

    (Street)
    NEW YORK NY 10154

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    Explanation of Responses:
    1. On February 11, 2026, Mozart Aggregator II LP contributed 14,394,340 shares of Class A Common Stock (the "Class A Common Stock") of Medline Inc. ("Issuer") previously held directly by it to Mozart Aggregator II UNLV Holdco L.P. No securities of the Issuer were purchased, sold or otherwise transferred in connection with the contributions described herein. Reporting Persons have agreed to be bound in writing by the restrictions set forth in the Lock Up Agreement entered into by and among Blackstone Inc. and its affiliates and the underwriters.
    2. On February 11, 2026, BCP Mozart Aggregator L.P. contributed 1,539 shares of Class A Common Stock of the Issuer, 9,501,507 shares of Class B common stock ("Class B Common Stock") of the Issuer and 9,501,507 common units of Medline Holdings, L.P. ("Common Units") previously held directly by it to Mozart Aggregator UNLV Holdco L.P. No securities of the Issuer were purchased, sold or otherwise transferred in connection with the contributions described herein. Reporting Persons have agreed to be bound in writing by the restrictions set forth in the Lock Up Agreement entered into by and among Blackstone Inc. and its affiliates and the underwriters.
    3. Reflects securities of the Issuer held directly by Mozart Aggregator II UNLV Holdco L.P. Mozart Aggregator II LP is the sole limited partner of Mozart Aggregator II UNLV Holdco L.P. Blackstone Management Associates VIII L.P. is the general partner of Mozart Aggregator II LP and of Mozart Aggregator II UNLV Holdco L.P. BMA VIII L.L.C. is the general partner of Blackstone Management Associates VIII L.P.
    4. Reflects securities of the Issuer held directly by Mozart Aggregator UNLV Holdco L.P. BCP Mozart Aggregator L.P. is the sole limited partner of Mozart Aggregator UNLV Holdco L.P. BCP 8 Holdings Mozart Manager L.L.C. is the general partner of BCP Mozart Aggregator L.P. and of Mozart Aggregator UNLV Holdco L.P. BMA VIII L.L.C. is the managing member of BCP 8 Holdings Mozart Manager L.L.C.
    5. Blackstone Holdings II L.P. is the managing member of BMA VIII L.L.C. Blackstone Holdings I/II GP L.L.C. is the general partner of Blackstone Holdings II L.P. Blackstone Inc. is the sole member of Blackstone Holdings I/II GP L.L.C. The sole holder of the Series II preferred stock of Blackstone Inc. is Blackstone Group Management L.L.C. Blackstone Group Management L.L.C. is wholly-owned by Blackstone's senior managing directors and controlled by its founder, Stephen A. Schwarzman.
    6. Shares of Class B Common Stock have no economic value and have one vote per share. One share of Class B Common Stock is issued for each Common Unit held. Upon an exchange of Common Units for shares of Class A Common Stock, an equivalent number of shares of Class B Common Stock held by such holder will be automatically cancelled.
    7. Pursuant to the terms of an exchange agreement, dated as of December 16, 2025, holders have the right to exchange their Common Units for shares of Class A Common Stock on a one-for-one basis, subject to customary conversion rate adjustments for stock splits, stock dividends and reclassifications. These exchange rights do not expire.
    8. Each such Reporting Person may be deemed to beneficially own the securities of the Issuer directly held by Mozart Aggregator UNLV Holdco L.P. and Mozart Aggregator II UNLV Holdco L.P. directly or indirectly controlled by it or him, but each (other than Mozart Aggregator UNLV Holdco L.P. and Mozart Aggregator II UNLV Holdco L.P. to the extent of their respective direct holdings) disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, and this report shall not be deemed an admission that any of the Reporting Persons (other than Mozart Aggregator UNLV Holdco L.P. and Mozart Aggregator II UNLV Holdco L.P. to the extent each directly holds securities of the Issuer) is the beneficial owner of such securities for purposes of Section 16 or any other purpose.
    9. Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person.
    MOZART AGGREGATOR UNLV HOLDCO L.P. By: BCP 8 Holdings Mozart Manager L.L.C., its general partner, By: BMA VIII L.L.C., its managing member, By: /s/ Robert Brooks Name: Robert Brooks, Title: Authorized Signatory 02/23/2026
    MOZART AGGREGATOR II UNLV HOLDCO L.P. By: BLACKSTONE MANAGEMENT ASSOCIATES VIII L.P., its general partner, By: BMA VIII L.L.C., its general partner, By: /s/ Robert Brooks Name: Robert Brooks, Title: Authorized Signatory 02/23/2026
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $MDLN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MDLN

    DatePrice TargetRatingAnalyst
    3/11/2026$60.00Buy
    Citigroup
    2/5/2026$55.00Buy
    Tigress Financial
    1/21/2026$50.00 → $55.00Buy
    BTIG Research
    1/12/2026$48.00Buy
    Citigroup
    1/12/2026$38.00Neutral
    BNP Paribas Exane
    1/12/2026$50.00Overweight
    Analyst
    1/12/2026$50.00Overweight
    Piper Sandler
    1/12/2026$48.00Overweight
    Morgan Stanley
    More analyst ratings

    $MDLN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Medline's growth continues as it breaks ground on 1.2 million sq. ft distribution center in Midlothian, Texas

    Groundbreaking is first operational initiative as a publicly traded company on its continued trajectory of growthNORTHFIELD, Ill., March 11, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN) announced during a groundbreaking event this week that it plans to expand its national network of 45 distribution centers across the U.S. by constructing a new 1.2 million sq. ft. distribution center in Midlothian, Texas. The distribution center is to be fully operational in Q2 of 2027 and is the first new DC announced by Medline in 2026 and after its initial public offering in December of last year.

    3/11/26 2:00:00 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Medline Inc. announces closing of secondary offering of Class A common stock and full exercise of underwriters' option to purchase additional shares

    NORTHFIELD, Ill., March 10, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (NASDAQ:MDLN) ("Medline") announced today that it has closed its secondary offering of 86,250,000 shares of Medline Inc.'s Class A common stock by certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the "Selling Stockholders") at a price to the public of $41.00 per share, including the full exercise by the underwriters of their option to purchase up to an additional 11,250,000 shares of Medline's Class A common stock. Medline did not sell any shares of Class A common stock in the offering and did not

    3/10/26 2:00:00 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Medline Awards Distribution Center of the Year and SAFE Awards

    NORTHFIELD, Ill., March 9, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN), the largest provider of medical-surgical products and supply chain solutions serving all points of care, announced this week its Distribution Center of the Year and Safety, Awareness for Everyone (SAFE) Award recipients to its top-performing facilities. These awards are given to the top-performing Medline distribution centers in the United States across its four tiers of size, as determined by the sales volume distributed out of each facility. Medline has been providing these awards to its highest-performing

    3/9/26 11:47:00 AM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    $MDLN
    SEC Filings

    View All

    SEC Form 424B4 filed by Medline Inc.

    424B4 - Medline Inc. (0002046386) (Filer)

    3/6/26 4:01:28 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    SEC Form EFFECT filed by Medline Inc.

    EFFECT - Medline Inc. (0002046386) (Filer)

    3/5/26 12:15:19 AM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    SEC Form S-1 filed by Medline Inc.

    S-1 - Medline Inc. (0002046386) (Filer)

    3/3/26 6:57:39 AM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    $MDLN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Gic Private Ltd sold $289,480,090 worth of shares (10,204,351 units at $28.37) and bought $364,999,974 worth of shares (12,586,206 units at $29.00) (SEC Form 4)

    4 - Medline Inc. (0002046386) (Issuer)

    12/22/25 5:26:57 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Director Mills Andrew J. was granted 30,655 units of Class B Common Stock and bought $74,999,974 worth of shares (2,586,206 units at $29.00) (SEC Form 4)

    4 - Medline Inc. (0002046386) (Issuer)

    12/22/25 4:30:06 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Director Mills Charles N. was granted 64,005 units of Class B Common Stock and bought $74,799,990 worth of shares (2,579,310 units at $29.00) (SEC Form 4)

    4 - Medline Inc. (0002046386) (Issuer)

    12/22/25 4:30:04 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    $MDLN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citigroup resumed coverage on Medline with a new price target

    Citigroup resumed coverage of Medline with a rating of Buy and set a new price target of $60.00

    3/11/26 8:38:58 AM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Tigress Financial initiated coverage on Medline with a new price target

    Tigress Financial initiated coverage of Medline with a rating of Buy and set a new price target of $55.00

    2/5/26 10:03:24 AM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    BTIG Research reiterated coverage on Medline with a new price target

    BTIG Research reiterated coverage of Medline with a rating of Buy and set a new price target of $55.00 from $50.00 previously

    1/21/26 1:17:48 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    $MDLN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Healy Patrick J acquired 577,510 shares, increasing direct ownership by 73% to 1,208,159 units (SEC Form 4)

    4 - Medline Inc. (0002046386) (Issuer)

    3/12/26 8:01:54 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,058,524,148 worth of shares (26,131,237 units at $40.51) and disposed of 2,088,086 shares (SEC Form 4)

    4 - Medline Inc. (0002046386) (Issuer)

    3/12/26 8:01:19 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Large owner Cp Circle Ml Holdco Gp, Llc sold $1,070,339,440 worth of shares (26,105,840 units at $41.00) and disposed of 2,113,483 shares (SEC Form 4)

    4 - Medline Inc. (0002046386) (Issuer)

    3/12/26 4:30:16 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    $MDLN
    Financials

    Live finance-specific insights

    View All

    Medline to report fourth quarter and full year 2025 results on February 25, 2026

    NORTHFIELD, Ill., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline") (NASDAQ:MDLN) today announced that it plans to report fourth quarter and full year 2025 financial results on Wednesday, February 25, 2026. A press release and supplemental materials will be issued before the market opens. The company will host a webcast and conference call at 9:30am ET/ 8:30am CT to discuss the financial results. Information about Medline's financial results, including a link to the live webcast, will be available on the Events page of Medline's Investor Relations website at ir.medline.com. A replay of the webcast will be available following the event through the same website. About MedlineMedli

    1/28/26 9:00:00 AM ET
    $MDLN
    Medical/Dental Instruments
    Health Care